Billerica, Massachusetts, November 11, 2016 — MilliporeSigma has received a prestigious R&D 100 Award for its Sanger Arrayed Lentiviral CRISPR Libraries—the first of its kind CRISPR libraries. R&D Magazine announced the awards at its 54th Annual R&D 100 Awards Dinner on Nov. 3 in Washington, D.C.

“Advancements in gene editing with tools like CRISPR are helping our customers discover and manufacture new treatments for the most difficult conditions,” said Udit Batra, CEO, MilliporeSigma. “We will continue to collaborate with the global scientific community to deliver the promise of their innovations faster and work to accelerate access to health for people everywhere.”

Recognition of these world-class products showcases the company’s commitment to empowering scientists and researchers with the solutions they need to develop new tools that can improve human health. The awards, known as the “Oscars of Invention,” honor the year’s 100 most innovative scientific and technological breakthroughs.

MillliporeSigma’s Sanger Arrayed Lentiviral CRISPR Libraries won in the Analytical/Test category. These libraries are the first human and mouse arrayed lentiviral CRISPR libraries for knocking out and screening gene function. The library allows discovery of genes involved in drug resistance, human disease and a wide variety of biological processes. Researchers can use the entire library to screen the entire genome or they can select specific genes and pathways to screen using the associated clones.

This is MilliporeSigma’s fifth year in a row receiving an R&D 100 Award. In 2015, the AFS water purification systems and Simplicon RNA Reprogramming Technology, were named in the process/prototyping and analytical/test categories, respectively. The R&D 100 Awards span industry, academia and government-sponsored research.